| Literature DB >> 36009146 |
Wen Gao1, Zhengzhe Cui2, Yang Yu1, Jing Mao1, Jun Xu1, Leilei Ji1, Xiuli Kan1, Xianshan Shen1, Xueming Li1, Shiqiang Zhu2,3, Yongfeng Hong1.
Abstract
(1) Objective: To investigate the feasibility, safety, and effectiveness of a brain-computer interface (BCI) system with visual and motor feedback in limb and brain function rehabilitation after stroke. (2)Entities:
Keywords: active rehabilitation training; brain function; brain–computer interface; motor function; stroke
Year: 2022 PMID: 36009146 PMCID: PMC9405856 DOI: 10.3390/brainsci12081083
Source DB: PubMed Journal: Brain Sci ISSN: 2076-3425
Information of the eight patients.
| Subject | Age | Gender | Sites of Injury | Course of Disease(d) | BCI Treatment Times |
|---|---|---|---|---|---|
| 1 | 58 | Male | Left basal ganglia cerebral hemorrhage | 34 | 4 |
| 2 | 31 | Male | Right basal ganglia cerebral hemorrhage | 127 | 4 |
| 3 | 55 | Female | Right basal ganglia cerebral infarction | 30 | 4 |
| 1′ | 34 | Male | Left cerebellar hemisphere hemorrhage | 41 | 26 |
| 2′ | 44 | Male | Left basal ganglia cerebral hemorrhage | 37 | 26 |
| 3′ | 51 | Male | Left basal ganglia cerebral infarction | 18 | 28 |
| 4′ | 52 | Female | left basal ganglia cerebral infarction | 15 | 24 |
| 5′ | 58 | Male | Left basal ganglia, left paraventricular cerebral infarction | 41 | 26 |
Figure 1Electrode placement diagram of L-B300 EEG Acquisition and Rehabilitation Training System.
Figure 2BCI training. (A) A patient with right hemiplegia undergoing upper limb BCI training (imagined swimming) (B) The same patient undergoing lower limb BCI training (imagined cycling). In the safety evaluation of the system, the three patients were observed and evaluated for any discomfort, seizures, recurrent cerebral hemorrhage, and cerebral infarction during training.
Figure 3The continuous motor state switching times of the three patients in the feasibility test.
Figure 4The motor state percentages (A) and the effective training revolutions per minute (B) of the three test patients in upper limb training at the two stages of training.
Figure 5The motor state percentage (A) and the effective training revolutions per minute (B) of the three pilot patients at the two stages of lower limb training.
Clinical efficacy evaluation (mean ± SD) of the five patients.
| Assessment Item | Before | After | Difference | Cohen’s w |
|---|---|---|---|---|
| Sitting balance ability | 2.4 ± 0.9 | 2.8 ± 0.5 | 0.4 ± 0.55 | 1.22 ** |
| Upper limb FMA | 22.2 ± 10.1 | 30.2 ± 8.9 | 8.0 ± 5.61 | 5.18 ** |
| Lower limb FMA | 19.6 ± 10.1 | 25.0 ± 5.7 | 5.4 ± 5.18 | 5.44 ** |
| 10 m walking speed | 0.5 ± 0.2 | 0.5 ± 0.2 | 0.04 ± 0.03 | 0.16 |
| 6MWD | 155.6 ± 50.0 | 167.0 ± 48.9 | 11.4 ± 4.30 | 2.29 ** |
| MBI | 65.0 ± 7.1 | 72.0 ± 7.6 | 7.0 ± 2.70 | 2.06 ** |
** (Cohen’s w ≥ 0.5) indicates a large effect size.
Comparison of the RMSs (mean ± SD) before and after treatment in the five patients.
| Assessment Item | Examined Position | Before | After | Difference | Cohen’s w |
|---|---|---|---|---|---|
| RMS (μV) | Biceps brachii | 2.9 ± 1.1 | 3.0 ± 1.1 | 0.2 ± 0.09 | 0.25 |
| Triceps brachii | 6.8 ± 7.7 | 7.0 ± 7.9 | 0.2 ± 0.25 | 0.20 | |
| Flexor digitorum | 0.6 ± 0.5 | 0.6 ± 0.4 | 0.0 ± 0.07 | 0.11 | |
| Extensor digitorum | 0.7 ± 0.8 | 0.7 ± 0.8 | 0.0 ± 0.01 | 0.06 | |
| Abductor pollicis brevis | 0.3 ± 0.2 | 0.3 ± 0.2 | 0.0 ± 0.03 | 0.08 | |
| Quadriceps femoris | 18.5 ± 12.5 | 19.0 ± 12.8 | 0.5 ± 0.68 | 0.35 * | |
| Hamstring muscle | 15.1 ± 8.0 | 15.5 ± 8.2 | 0.4 ± 0.35 | 0.24 | |
| Anterior tibial muscle | 9.0 ± 6.4 | 9.1 ± 6.5 | 0.2 ± 0.14 | 0.14 | |
| Triceps surae | 10.0 ± 6.5 | 10.8 ± 7.6 | 0.9 ± 1.06 | 0.71 ** |
** (Cohen’s w ≥ 0.5) indicates a large effect size, * (Cohen’s w < 0.5 and ≥0.3) indicates a medium effect size.
Comparison of the MEPs (mean ± SD) before and after treatment in the five patients.
| Assessment Item | Examined Position | Testing Indicator | Before | After | Difference | Cohen’s w |
|---|---|---|---|---|---|---|
| MEP | M1 area on the non-lesion side | Latent period (ms) | 42.1 ± 8.3 | 39.5 ± 8.6 | −2.6 ± 2.17 | 1.11 ** |
| Amplitude (10−5) | 32.7 ± 10.9 | 36.2 ± 9.0 | 3.6 ± 3.78 | 2.41 ** | ||
| M1 area on the lesion side | Latent period (ms) | 14.4 ± 5.7 | 13.8 ± 5.9 | −0.6 ± 0.39 | 0.44 * | |
| Amplitude (10−5) | 20.0 ± 7.7 | 23.9 ± 7.8 | 3.7 ± 3.89 | 2.83 ** |
** (Cohen’s w ≥ 0.5) indicates a large effect size, * (Cohen’s w < 0.5 and ≥0.3) indicates a medium effect size.